通过肾脏配对捐赠拓展活体捐赠的边界
活体供肾移植是晚期肾病首选治疗,肾脏配对捐赠(KPD)最初用于克服免疫障碍,现已扩展至解决生物学和时间不兼容及经济障碍。2021年美国5971例活体供肾移植中1115例(18.6%)经KPD完成,但40%移植中心未提供KPD,且私有KPD项目主导,供者保护不均。本文呼吁国家监管和供者经济中立。
要点
- KPD可克服免疫及时间不兼容,2021年美国18.6%活体供肾移植经KPD完成。
- 参与不普遍:40%移植中心未提供KPD,且私有项目主导,供者保护不均。
- 需国家监管和供者经济中立,以提高KPD可及性和公平性。
核心结论
- KPD已从克服免疫障碍扩展至解决生物学和时间不兼容及经济障碍,但参与不普遍且供者保护不均。
- 需国家行动加强监管并实现活体供肾经济中立,以最大化活体供肾移植机会。
研究设计与样本
- 本文为观点性综述,回顾KPD项目演变并讨论参与障碍及政策建议。
- 引用2021年美国活体供肾移植数据:5971例中1115例(18.6%)经KPD完成。
主要发现
- 2021年美国5971例活体供肾移植中1115例(18.6%)由KPD促成。
- 40%的移植中心未提供KPD,美国大片区域无提供KPD的移植中心。
- 部分私有KPD项目为活体供者提供财务和法律保护,但并非所有供者均可获得。
临床怎么用
- 肾内科医生应向供受者候选人透明告知活体供肾选项包括KPD。
- 鼓励移植中心参与KPD以扩大活体供肾移植机会。
局限性
- 本文为观点性综述,未提供原始研究数据或系统评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Living-donor kidney transplant (LDKT) is the treatment of choice for patients with advanced kidney disease. Kidney paired donation (KPD), originally proposed to overcome immunological barriers, has now evolved to address biological and chronological incompatibilities and reduce financial disincentives. This strategy has allowed the maximization of the number of LDKTs. In 2021, of the 5,971 LDKTs performed, 1,115 (18.6%) were facilitated by KPD. Although KPD programs vary in size and structure, privately owned KPD programs dominate the landscape. Participation in KPD is far from universal: it is not offered in 40% of transplant centers. Across the United States, there are large areas devoid of transplant centers that offer KPD. As a result, some donor and recipient candidates are missing opportunities for a successful LDKT. Some private KPD programs provide financial and legal protections to living donors. Therefore, access to such donor protections is variable and not available to all donors. In this perspective, we review the evolution of KPD programs, explore ways to enhance participation, discuss the need for transparency about living donation options to donor and recipient candidates, and ultimately call for national action for regulatory oversight and to make living kidney donation financially neutral regardless of participation in KPD.
引用
- Kumar A, Nishio Lucar AG, Doshi MD, et al. Pushing the Boundaries of Living Donation Through Kidney Paired Donation. Am J Kidney Dis. 2024. PMID: 39706246. doi:10.1053/j.ajkd.2024.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。